July 24, 2017 5:46 PM ET

Pharmaceuticals

Company Overview of Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Company Overview

Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and marketing of biological products in China. Its products include Su peptide, an injection of mouse nerve growth factor; Shu Taiqing, a polyethylene glycol powder for bowel and constipation indications; Shu Wei Yan, a trospium chloride capsule for the treatment of overactive bladder; and aspirin enteric-coated tablets, glicre tablets, naproxen capsules, and other products. The company was founded in 2002 and is based in Beijing, China.

Beijing Economic and Technological Development Zone

No. 36, Jinghai Er Road

Beijing,  100176

China

Founded in 2002

Phone:

86 10 6751 9888

Fax:

86 10 6751 9794

Key Executives for Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. does not have any Key Executives recorded.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Key Developments

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Approves Amendments to Articles of Association

Staidson (Beijing) Biopharmaceuticals Co., Ltd. approved amendments to the company's articles of association, at the Annual General Meeting held on 18 April 2017.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. Approves Cash Dividend for the Year 2016

Staidson (Beijing) Biopharmaceuticals Co., Ltd. approved cash dividend (tax included) of CNY 1.80000000 per 10 shares for the year 2016, at its annual general meeting held on April 18, 2017.

Staidson (Beijing) Biopharmaceuticals Co., Ltd. to Report Q1, 2017 Results on Apr 20, 2017

Staidson (Beijing) Biopharmaceuticals Co., Ltd. announced that they will report Q1, 2017 results on Apr 20, 2017

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Staidson (Beijing) Biopharmaceuticals Co., Ltd., please visit www.staidson.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.